Do Not Treat Asymptomatic Group C Streptococcus Colonization
Antibiotics are not indicated for asymptomatic Group C streptococcal colonization in a 42-year-old adult, because Group C streptococci have not been definitively linked to acute rheumatic fever—the primary justification for treating streptococcal pharyngitis—and a positive culture without symptoms likely represents colonization rather than active infection. 1
Why Group C Streptococcus Differs from Group A
No rheumatic fever risk: The Infectious Diseases Society of America explicitly states that antimicrobial therapy for acute pharyngitis is indicated only for Group A Streptococcus (GAS) to prevent acute rheumatic fever and suppurative complications; β-hemolytic streptococci other than GAS are not targeted for routine treatment. 1
Current evidence shows that Group C (and G) streptococci have not been definitively linked to acute rheumatic fever, eliminating the primary justification for antibiotic therapy that exists for GAS pharyngitis. 1
Colonization versus infection: A positive Group C streptococcal culture in the setting of minimal or no symptoms is more likely to represent asymptomatic colonization rather than active infection. 1
Clinical Assessment Required
Symptom severity threshold: Adults presenting with only minimal symptoms or who are completely asymptomatic do not meet the clinical criteria for bacterial pharyngitis that warrants antibiotics. 1
When Group C causes true infection: Group C streptococci can occasionally cause invasive disease (pneumonitis, sinusitis, septicemia, endocarditis, osteomyelitis, meningitis), but these are symptomatic infections requiring clinical diagnosis, not asymptomatic colonization. 2
Pharyngitis presentation: When Group C does cause pharyngitis, patients typically present with fever, exudate, and cervical adenopathy similar to GAS pharyngitis—not asymptomatic colonization. 3
Management Approach
Do not treat solely on culture results when clinical symptoms are minimal or absent; doing so leads to unnecessary antibiotic exposure and promotes antimicrobial resistance. 1
Do not assume all β-hemolytic streptococci require therapy; only Group A streptococcus has established associations with acute rheumatic fever and serious sequelae that justify routine treatment of pharyngitis. 1
No routine follow-up testing: The IDSA recommends no routine follow-up testing for patients who are asymptomatic after a positive Group C streptococcal culture, nor for their household contacts. 1
Key Pitfalls to Avoid
Do not test or treat asymptomatic household contacts of patients with Group C streptococcal pharyngitis, as there is no evidence of benefit and it may contribute to overtreatment. 1
Avoid treating colonization as infection: Asymptomatic colonization with various organisms is common and does not warrant antimicrobial therapy in the absence of clinical disease. 4, 5
Recognize that treatment of asymptomatic colonization promotes resistance: Strategies that require widespread use of antimicrobial agents to suppress or eradicate colonizing organisms tend to promote emergence of multidrug-resistant pathogens. 4
When Treatment Would Be Indicated
If the patient develops symptomatic pharyngitis with fever, severe sore throat, tonsillar exudates, and tender cervical lymphadenopathy, then treatment with penicillin G would be appropriate, as penicillin is the antimicrobial agent of choice for infections due to group C streptococci. 2
For invasive Group C infections (septicemia, endocarditis, osteomyelitis, meningitis), penicillin G remains first-line therapy, though minimum inhibitory and minimum bactericidal concentrations should be determined since penicillin tolerance may occur. 2